최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Otology & neurotology, v.35 no.9, 2014년, pp.1673 - 1678
Chung, Jae Ho (Departments of *Otolaryngology–) , Park, Chul Won (Head and Neck Surgery and †Neurology, School of Medicine, Hanyang University, Seoul, Korea) , Lee, Seung Hwan , Kim, Beom Seok , Cho, Seok Hyun , Kim, Hyun Young , Kim, Seung Hyun
OBJECTIVE: To investigate adjuvant effect and safety of intratympanic steroid for the treatment of Bell’s palsy. STUDY DESIGN: Prospective, investigator blinded, randomized study. SETTING: Tertiary referral center. PATIENTS: Patients who received treatment for Bell’s palsy from December 2007 to March 2011 were randomly divided into two groups. The control group (n = 17) was treated with systemic steroid plus antiviral agent, and intratympanic steroid injection group (IT group, n = 14) received intratympanic steroid injection combined with medications. Facial functions were evaluated on a regular basis up to 6 months. INTERVENTION: Intratympanic steroid injection. MAIN OUTCOME MEASURES: Facial nerve functions of initial presentation and follow-up were evaluated with House-Brackmann (H-B) system. Primary outcome was complete recovery rate of 6 months. Secondary outcomes included improvement of H-B grade within 3 weeks, time of first improvement in facial function, and cumulative recovery rate. In addition, subgroup analysis of H-B grade over than IV was performed. RESULTS: Complete recovery rate was not different between groups. Time of first improvement was shorter in IT group (p = 0.043). And IT group had a better cumulative recovery rate (p = 0.041) and showed the significant improvement in H-B grade within 3 weeks compared with control group (p = 0.045). In severe facial palsy, complete recovery rate of IT group and control group were 80% and 50% (p = 0.16), and IT groups showed the significant facial improvement within 3 weeks (p = 0.025). And there were no major adverse effects of intratympanic injection. CONCLUSION: Intratympanic steroid injection might be a safe and useful adjuvant treatment modality for Bell’s palsy.
Acta Ophthalmol Scand Grzybowski 85 897 2007 10.1111/j.1600-0420.2007.00972.x Sir Charles Bell (1774-1842): contributions to neuro-ophthalmology.
Rev Med Virol McCormick 10 285 2000 10.1002/1099-1654(200009/10)10:5<285::AID-RMV269>3.0.CO;2-H Herpes simplex virus as a cause of Bells palsy. 1972.
Clin Otolaryngol Axelsson 37 283 2012 10.1111/j.1749-4486.2012.02526.x Bells palsythe effect of prednisolone andor valaciclovir versus placebo in relation to baseline severity in a randomised controlled trial.
Am Fam Physician Tiemstra 76 997 2007 Bells palsy: diagnosis and management.
Laryngoscope Bryant 83 700 1973 10.1288/00005537-197305000-00006 Intratympanic injection of steroid for treatment of facial paralysis.
Laryngoscope Filipo 123 774 2013 10.1002/lary.23678 Intratympanic steroid therapy in moderate sudden hearing loss: a randomized, triple-blind, placebo-controlled trial.
Otolaryngol Head Neck Surg House 93 146 1985 10.1177/019459988509300202 Facial nerve grading system.
Eur Arch Otorhinolaryngol Finsterer 265 743 2008 10.1007/s00405-008-0646-4 Management of peripheral facial nerve palsy.
New Engl J M Sullivan 357 1598 2007 10.1056/NEJMoa072006 Early treatment with prednisolone or acyclovir in Bells palsy.
J Neurol Minnerop 255 1726 2008 10.1007/s00415-008-0008-6 Bells palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone.
Am J Med Sci Rothendler 225 358 1953 10.1097/00000441-195304000-00002 Bells palsy treated with cortisone.
Cochrane Database Syst Rev Salinas 17 CD001942 2010 Corticosteroids for Bells palsy (idiopathic facial paralysis).
Neurology Gronseth 79 2209 2012 10.1212/WNL.0b013e318275978c Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology.
Arch Otolaryngol Head Neck Surg Berg 138 445 2012 10.1001/archoto.2012.513 The effect of prednisolone on sequelae in Bells palsy.
Acta Otolaryngol Suppl Itoh 481 617 1991 10.3109/00016489109131486 Treatment of vestibular disorders.
Otolaryngol Head Neck Surg Spear 145 534 2011 10.1177/0194599811419466 Intratympanic steroids for sudden sensorineural hearing loss: a systematic review.
Eur Arch Otorhinolaryngol Di Martino 262 120 2005 10.1007/s00405-004-0867-0 Fallopian canal dehiscences: a survey of clinical and anatomical findings.
J Laryngol Otol Baxter 85 587 1971 10.1017/S0022215100073849 Dehiscence of the Fallopian canal. An anatomical study.
Ann Otol Rhinol Laryngol Takahashi 101 925 1992 10.1177/000348949210101108 Facial canal dehiscence: histologic study and computer reconstruction.
Laryngoscope Moreano 104 309 1994 Prevalence of facial canal dehiscence and of persistent stapedial artery in the human middle ear: a report of 1000 temporal bones.
Int J Pediatr Otorhinolaryngol Perez 40 51 1997 10.1016/S0165-5876(97)01499-7 Incidence of dehiscences in the fallopian canal.
J Am Dent Assoc Slavkin 130 269 1999 10.14219/jada.archive.1999.0178 The significance of a human smile: observations on Bells palsy.
Acta Clin Croat Basic-Kes 52 195 2013 Peripheral facial weakness (Bells palsy).
※ AI-Helper는 부적절한 답변을 할 수 있습니다.